The members of the Methamphetamine Treatment Project are listed at the end of the manuscript.
Identifying Methamphetamine Users at Risk for Major Depressive Disorder: Findings from the Methamphetamine Treatment Project at Three-Year Follow-Up
Version of Record online: 18 FEB 2010
2008 American Academy of Addiction Psychiatry
The American Journal on Addictions
Volume 17, Issue 2, pages 99–102, March-April 2008
How to Cite
Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang, A., Rawson, R. and the Methamphetamine Treatment Project Corporate Authors (2008), Identifying Methamphetamine Users at Risk for Major Depressive Disorder: Findings from the Methamphetamine Treatment Project at Three-Year Follow-Up. The American Journal on Addictions, 17: 99–102. doi: 10.1080/10550490701861110
- Issue online: 18 FEB 2010
- Version of Record online: 18 FEB 2010
- Received April 03, 2007; revised June 12, 2007; accepted July 04, 2007
Little is known about risk factors for depression in methamphetamine users. Using data from 526 adults in the largest psychosocial clinical trial of methamphetamine users conducted to date, this study examined clinical, demographic, and substance use characteristics that predict the presence of a diagnosis of major depressive disorder (MDD) three years after treatment for methamphetamine dependence. The results indicate that two risk factors predict a diagnosis of MDD: a Beck Depression Inventory total score greater than 20, and one or more prior suicide attempts. These risk factors identify methamphetamine users who may benefit from early interventions for psychiatric symptoms.